Search and analyze individual stocks with comprehensive metrics
Unichem Laboratories Ltd
Fundamental Score
Unichem Laboratories Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of UNICHEMLAB across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Attractive Valuation (P/E: 22.07 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Robust Profit Growth (83.92%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Consistent Growth Track Record (13.85% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (29.11% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (29.11% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.21)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (6.86x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (70.22%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
4 factors identified
Below-Average Return on Equity (5.59%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.24%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Negative Free Cash Flow (₹-905.71 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Loading Peer Comparison
Finding companies in the Pharmaceuticals sector...
Financial Statements
Comprehensive financial data for Unichem Laboratories Ltd
About UNICHEMLAB
Business Overview
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited is a subsidiary of Ipca Laboratories Limited.
Company Details
Key Leadership
Corporate Events
UNICHEMLAB Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Unichem Laboratories Ltd (UNICHEMLAB)?
As of 20 Jan 2026, 11:00 am IST, Unichem Laboratories Ltd (UNICHEMLAB) is currently trading at ₹384.40. The stock has a market capitalization of ₹3.21K (Cr).
Is UNICHEMLAB share price Overvalued or Undervalued?
UNICHEMLAB is currently trading at a P/E ratio of 22.07x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Unichem Laboratories Ltd share price?
Key factors influencing UNICHEMLAB's price include its quarterly earnings growth (Sales Growth: 14.11%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Unichem Laboratories Ltd a good stock for long-term investment?
Unichem Laboratories Ltd shows a 5-year Profit Growth of 29.11% and an ROE of 5.59%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.21 before investing.
How does Unichem Laboratories Ltd compare with its industry peers?
Unichem Laboratories Ltd competes with major peers in the Pharmaceuticals. Investors should compare UNICHEMLAB's P/E of 22.07x and ROE of 5.59% against the industry averages to determine its competitive standing.
What is the P/E ratio of UNICHEMLAB and what does it mean?
UNICHEMLAB has a P/E ratio of 22.07x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹22 for every ₹1 of annual earnings.
How is UNICHEMLAB performing according to Bull Run's analysis?
UNICHEMLAB has a Bull Run fundamental score of 56.7/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does UNICHEMLAB belong to?
UNICHEMLAB operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Unichem Laboratories Ltd.
What is Return on Equity (ROE) and why is it important for UNICHEMLAB?
UNICHEMLAB has an ROE of 5.59%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Unichem Laboratories Ltd generates profits from shareholders' equity.
How is UNICHEMLAB's debt-to-equity ratio and what does it indicate?
UNICHEMLAB has a debt-to-equity ratio of 0.21, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is UNICHEMLAB's dividend yield and is it a good dividend stock?
UNICHEMLAB offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has UNICHEMLAB grown over the past 5 years?
UNICHEMLAB has achieved 5-year growth rates of: Sales Growth 13.85%, Profit Growth 29.11%, and EPS Growth 29.11%.
What is the promoter holding in UNICHEMLAB and why does it matter?
Promoters hold 70.22% of UNICHEMLAB shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is UNICHEMLAB's market capitalization category?
UNICHEMLAB has a market capitalization of ₹3215 crores, placing it in the Small-cap category.
How volatile is UNICHEMLAB stock?
UNICHEMLAB has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for UNICHEMLAB?
UNICHEMLAB has a 52-week high of ₹N/A and low of ₹N/A.
What is UNICHEMLAB's operating profit margin trend?
UNICHEMLAB has a 5-year average Operating Profit Margin (OPM) of 6.06%, indicating the company's operational efficiency.
How is UNICHEMLAB's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 14.11% and YoY Profit Growth of 83.92%.
What is the institutional holding pattern in UNICHEMLAB?
UNICHEMLAB has FII holding of 0.99% and DII holding of 10.74%. Significant institutional holding often suggests professional confidence in the stock.